Association of RNASEL and 8q24 variants with the presence and aggressiveness of hereditary and sporadic prostate cancer in a hispanic population

Journal of Cellular and Molecular Medicine

Volumn 18, Issue 1, 2014, Pages 125-133

  San Francisco, Ignacio F ^a   Rojas, Pablo A ^a   Torres Estay, Verónica ^b   Smalley, Susan ^a   Cerda Infante, Javier ^a   Montecinos, Viviana P ^a   Hurtado, Claudia ^c   Godoy, Alejandro S ^b,d  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^c CLÍNICA LAS CONDES   (Chile)

^d ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

8q24; Polymorphism; Prostate cancer; RNASEL; Rs6983267

Indexed keywords

2 5A DEPENDENT RIBONUCLEASE; 2-5A-DEPENDENT RIBONUCLEASE; RIBONUCLEASE;

8Q24; AGED; ARTICLE; CANCER GRADING; CASE CONTROL STUDY; CHILE; CHROMOSOME 8; DNA SEQUENCE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETICS; HUMAN; MALE; MIDDLE AGED; PATHOLOGY; POLYMORPHISM; PROSTATE CANCER; PROSTATE TUMOR; RISK; RNASEL; RS6983267; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR VOLUME;

8Q24; POLYMORPHISM; PROSTATE CANCER; RNASEL; RS6983267;

AGED; CASE-CONTROL STUDIES; CHILE; CHROMOSOMES, HUMAN, PAIR 8; ENDORIBONUCLEASES; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSTATIC NEOPLASMS; RISK; SEQUENCE ANALYSIS, DNA; TUMOR BURDEN;

EID: 84891371997     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/jcmm.12171     Document Type: Article

References (30)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012; 62: 10-29.
2. Ministerio de Salud C. Primer informe de registros poblacionales de cancer de Chile quinquenio 2003-2007. http://epi.minsal.cl/epi/0notransmisibles/cancer/INFORME%20RPC%20CHILE%202003-2007, %20UNIDAD%20VENT, %20DEPTO.EPIDEMIOLOGIA-MINSAL, 13.04.2012.pdf
3. San Francisco IF, Regan MM, Dewolf WC, et al. Low age adjusted free testosterone levels correlate with poorly differentiated prostate cancer. J Urol. 2006; 175: 1341-5; discussion 5-6.
4. San Francisco IF, Regan MM, Olumi AF, et al. Percent of cores positive for cancer is a better preoperative predictor of cancer recurrence after radical prostatectomy than prostate specific antigen. J Urol. 2004; 171: 1492-9.
5. Smith JR, Freije D, Carpten JD, et al. Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search. Science. 1996; 274: 1371-4.
6. Shook SJ, Beuten J, Torkko KC, et al. Association of RNASEL variants with prostate cancer risk in Hispanic Caucasians and African Americans. Clin Cancer Res. 2007; 13: 5959-64.
7. Rennert H, Bercovich D, Hubert A, et al. A novel founder mutation in the RNASEL gene, 471delAAAG, is associated with prostate cancer in Ashkenazi Jews. Am J Hum Genet. 2002; 71: 981-4.
8. Rokman A, Ikonen T, Seppala EH, et al. Germline alterations of the RNASEL gene, a candidate HPC1 gene at 1q25, in patients and families with prostate cancer. Am J Hum Genet. 2002; 70: 1299-304.
9. Zheng SL, Sun J, Wiklund F, et al. Cumulative association of five genetic variants with prostate cancer. N Engl J Med. 2008; 358: 910-9.
10. Al Olama AA, Kote-Jarai Z, Giles GG, et al. Multiple loci on 8q24 associated with prostate cancer susceptibility. Nat Genet. 2009; 41: 1058-60.
11. Yeager M, Chatterjee N, Ciampa J, et al. Identification of a new prostate cancer susceptibility locus on chromosome 8q24. Nat Genet. 2009; 41: 1055-7.
12. Penney KL, Salinas CA, Pomerantz M, et al. Evaluation of 8q24 and 17q risk loci and prostate cancer mortality. Clin Cancer Res. 2009; 15: 3223-30.
13. Beuten J, Gelfond JA, Martinez-Fierro ML, et al. Association of chromosome 8q variants with prostate cancer risk in Caucasian and Hispanic men. Carcinogenesis. 2009; 30: 1372-9.
14. Thompson IM, Pauler DK, Goodman PJ, et al. Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter. N Engl J Med. 2004; 350: 2239-46.
15. Keetch DW, Catalona WJ, Smith DS. Serial prostatic biopsies in men with persistently elevated serum prostate specific antigen values. J Urol. 1994; 151: 1571-4.
16. Leite KR, Camara-Lopes LH, Cury J, et al. Prostate cancer detection at rebiopsy after an initial benign diagnosis: results using sextant extended prostate biopsy. Clinics. 2008; 63: 339-42.
17. Pepe P, Aragona F. Saturation prostate needle biopsy and prostate cancer detection at initial and repeat evaluation. Urology. 2007; 70: 1131-5.
18. Roehl KA, Antenor JA, Catalona WJ. Serial biopsy results in prostate cancer screening study. J Urol. 2002; 167: 2435-9.
19. Carter BS, Bova GS, Beaty TH, et al. Hereditary prostate cancer: epidemiologic and clinical features. J Urol. 1993; 150: 797-802.
20. Sole X, Guino E, Valls J, et al. SNPStats: a web tool for the analysis of association studies. Bioinformatics. 2006; 22: 1928-9.
21. Iniesta R, Guino E, Moreno V. Statistical analysis of genetic polymorphisms in epidemiological studies. Gac Sanit. 2005; 19: 333-41.
22. Wei B, Xu Z, Ruan J, et al. RNASEL Asp541Glu and Arg462Gln polymorphisms in prostate cancer risk: evidences from a meta-analysis. Mol Biol Rep. 2012; 39: 2347-53.
23. Nakazato H, Suzuki K, Matsui H, et al. Role of genetic polymorphisms of the RNASEL gene on familial prostate cancer risk in a Japanese population. Br J Cancer. 2003; 89: 691-6.
24. Cornu JN, Drouin S, Cancel-Tassin G, et al. Impact of genotyping on outcome of prostatic biopsies: a multicenter prospective study. Mol Med. 2011; 17: 473-7.
25. Lange EM, Salinas CA, Zuhlke KA, et al. Early onset prostate cancer has a significant genetic component. Prostate. 2012; 72: 147-56.
26. Papanikolopoulou A, Landt O, Ntoumas K, et al. The multi-cancer marker, rs6983267, located at region 3 of chromosome 8q24, is associated with prostate cancer in Greek patients but does not contribute to the aggressiveness of the disease. Clin Chem Lab Med. 2012; 50: 379-85.
27. Cheng I, Plummer SJ, Jorgenson E, et al. 8q24 and prostate cancer: association with advanced disease and meta-analysis. Eur J Hum Genet. 2008; 16: 496-505.
28. Troutman SM, Sissung TM, Cropp CD, et al. Racial disparities in the association between variants on 8q24 and prostate cancer: a systematic review and meta-analysis. Oncologist. 2012; 17: 312-20.
29. Dai J, Hall CL, Escara-Wilke J, et al. Prostate cancer induces bone metastasis through Wnt-induced bone morphogenetic protein-dependent and independent mechanisms. Cancer Res. 2008; 68: 5785-94.
30. Liu H, Wang B, Han C. Meta-analysis of genome-wide and replication association studies on prostate cancer. Prostate. 2011; 71: 209-24.